Carregant...
Gamma synchrony: towards a translational biomarker for the treatment resistant symptoms of schizophrenia
The lack of efficacy for antipsychotics with respect to negative symptoms and cognitive deficits is a significant obstacle for the treatment of schizophrenia. Developing new drugs to target these symptoms requires appropriate neural biomarkers that can be investigated in model organisms, be used to...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3264822/ https://ncbi.nlm.nih.gov/pubmed/21349276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2011.02.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|